Ruslana Bryk

2.7k citations

25 papers · 2.0k indexed · 1 hit paper · h-index 17

Co-authors: Carl Nathan Patrick R. Griffin Hediye Erdjument‐Bromage Paul Tempst Christopher D. Lima Donald J. Wolff Kyu Y. RheeJing Tian
Topics: Biochemical and Molecular Research (15 papers)Tuberculosis Research and Epidemiology (9 papers)Biochemical Acid Research Studies (7 papers)
Cited by: Biochemistry Infectious Diseases Molecular Medicine
Journals: Nature Science Proceedings of the National Academy of Sciences
Partner nations: United States China Japan

In The Last Decade

Ruslana Bryk

25 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Peroxynitrite reductase activity of bacterial peroxiredoxins

2000 557 citations Ruslana Bryk, Patrick R. Griffin et al. Nature profile →

Peers

Countries citing papers authored by Ruslana Bryk

Since Specialization

Citations

This map shows the geographic impact of Ruslana Bryk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruslana Bryk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruslana Bryk more than expected).

Fields of papers citing papers by Ruslana Bryk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruslana Bryk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruslana Bryk. The network helps show where Ruslana Bryk may publish in the future.

Co-authorship network of co-authors of Ruslana Bryk

This figure shows the co-authorship network connecting the top 25 collaborators of Ruslana Bryk. A scholar is included among the top collaborators of Ruslana Bryk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruslana Bryk. Ruslana Bryk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ACOD1-mediated lysosomal membrane permeabilization contributes to Mycobacterium tuberculosis –induced macrophage death 2025 ·Proceedings of the National Academy of Sciences ·Ziwei Yang,Li Zhang,(unknown),Jacob B. Geri,Andrew J. Perkowski,Xiuju Jiang,(unknown),Ruslana Bryk,Jeffrey Aubé,Matthew Zimmerman,Véronique Dartois,Carl Nathan	2
2	Indazole to 2‐Cyanoindole Scaffold Progression for Mycobacterial Lipoamide Dehydrogenase Inhibitors Achieves Extended Target Residence Time and Improved Antibacterial Activity 2024 ·Angewandte Chemie ·(unknown),John D. Ginn,Tomasz Kochańczyk,(unknown),Xiuju Jiang,David J. Huggins,James Bean,Mayako Michino,Leigh A. Baxt,Nigel J. Liverton,Peter T. Meinke,Ruslana Bryk	1
3	Indazole to 2‐Cyanoindole Scaffold Progression for Mycobacterial Lipoamide Dehydrogenase Inhibitors Achieves Extended Target Residence Time and Improved Antibacterial Activity 2024 ·Angewandte Chemie International Edition ·(unknown),John D. Ginn,Tomasz Kochańczyk,(unknown),Xiuju Jiang,David J. Huggins,James Bean,Mayako Michino,Leigh A. Baxt,Nigel J. Liverton,Peter T. Meinke,Ruslana Bryk	3
4	Shape-Based Virtual Screening of a Billion-Compound Library Identifies Mycobacterial Lipoamide Dehydrogenase Inhibitors 2023 ·SHILAP Revista de lepidopterología ·Mayako Michino,Alexandre Beautrait,Nicholas A. Boyles,(unknown),Alexey Dementiev,(unknown),John D. Ginn,Leigh A. Baxt,R.K. Suto,Ruslana Bryk,Steven V. Jerome,David J. Huggins,Jérémie Vendôme	7
5	Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford Selectivity over the Human Enzyme through Tight Binding Interactions 2021 ·ACS Infectious Diseases ·John D. Ginn,Xiuju Jiang,(unknown),Mayako Michino,David J. Huggins,(unknown),Robert S. Jansen,Kyu Y. Rhee,(unknown),Christopher D. Lima,Nigel J. Liverton,Toshihiro Imaeda,Rei Okamoto,Takanobu Kuroita,Kazuyoshi Aso,Andrew W. Stamford,Michael A. Foley,Peter T. Meinke,Carl Nathan,Ruslana Bryk	5
6	Comparison of transposon and deletion mutants in Mycobacterium tuberculosis : The case of rv1248c , encoding 2-hydroxy-3-oxoadipate synthase 2015 ·Tuberculosis ·(unknown),Thomas R. Ioerger,Anand Balakrishnan,Ruslana Bryk,Kyu Y. Rhee,James C. Sacchettini,Carl Nathan	5
7	Lipoamide Channel-Binding Sulfonamides Selectively Inhibit Mycobacterial Lipoamide Dehydrogenase 2013 ·Biochemistry ·Ruslana Bryk,(unknown),(unknown),Anand Balakrishnan,Ying‐Ta Wu,Chi‐Huey Wong,Thierry Masquelin,Philip A. Hipskind,Christopher D. Lima,Carl Nathan	17
8	Virulence of Mycobacterium tuberculosis Depends on Lipoamide Dehydrogenase, a Member of Three Multienzyme Complexes 2011 ·Cell Host & Microbe ·Aditya Venugopal,Ruslana Bryk,Shuangping Shi,Kyu Y. Rhee,Poonam Rath,Dirk Schnappinger,Sabine Ehrt,Carl Nathan	106
9	Central carbon metabolism in Mycobacterium tuberculosis: an unexpected frontier 2011 ·Trends in Microbiology ·Kyu Y. Rhee,Luiz Pedro S. de Carvalho,Ruslana Bryk,Sabine Ehrt,Joeli Marrero,Sae Woong Park,Dirk Schnappinger,Aditya Venugopal,Carl Nathan	128
10	Identification of new inhibitors of protein kinase R guided by statistical modeling 2011 ·Bioorganic & Medicinal Chemistry Letters ·Ruslana Bryk,Kangyun Wu,Brian C. Raimundo,(unknown),Ping Chao,Graeme L. Conn,Eric H. Anderson,James L. Cole,Nigel Duffy,Carl Nathan,John H. Griffin	17
11	A philosophy of anti-infectives as a guide in the search for new drugs for tuberculosis 2008 ·Tuberculosis ·Carl Nathan,Ben Gold,Gang Lin,Melanie A. Stegman,Luiz Pedro S. de Carvalho,Omar Vandal,Aditya Venugopal,Ruslana Bryk	46
12	Selective Killing of Nonreplicating Mycobacteria 2008 ·Cell Host & Microbe ·Ruslana Bryk,Benjamin D. Gold,Aditya Venugopal,Jasbir Singh,(unknown),Krzysztof Pupek,Hua Cao,Carmen Florentina Popescu,(unknown),Srinivas Hotha,Joseph Cherian,Kyu Y. Rhee,Lan H. Ly,Paul J. Converse,Sabine Ehrt,Omar Vandal,Xiuju Jiang,(unknown),Gang Lin,Carl Nathan	130
13	Identification of a copper-binding metallothionein in pathogenic mycobacteria 2008 ·Nature Chemical Biology ·Ben Gold,Haiteng Deng,Ruslana Bryk,Diana Vargas,David Eliezer,Julia Roberts,Xiuju Jiang,Carl Nathan	162
14	Crystal Structure and Functional Analysis of Lipoamide Dehydrogenase from Mycobacterium tuberculosis 2005 ·Journal of Biological Chemistry ·Kanagalaghatta R. Rajashankar,Ruslana Bryk,R. Kniewel,John A. Buglino,Carl Nathan,Christopher D. Lima	29
15	Mycobacterium tuberculosis appears to lack α‐ketoglutarate dehydrogenase and encodes pyruvate dehydrogenase in widely separated genes 2005 ·Molecular Microbiology ·Jing Tian,Ruslana Bryk,Shuangping Shi,Hediye Erdjument‐Bromage,Paul Tempst,Carl Nathan	77
16	Variant tricarboxylic acid cycle in Mycobacterium tuberculosis : Identification of α-ketoglutarate decarboxylase 2005 ·Proceedings of the National Academy of Sciences ·Jing Tian,Ruslana Bryk,Manabu Itoh,Makoto Suematsu,Carl Nathan	156
17	Peroxynitrite reductase activity of bacterial peroxiredoxinsbreakdown → 2000 ·Nature ·Ruslana Bryk,Patrick R. Griffin,Carl Nathan	557
18	Studies of Neuronal Nitric Oxide Synthase Inactivation by Diverse Suicide Inhibitors 1999 ·Archives of Biochemistry and Biophysics ·Ruslana Bryk,(unknown),Donald J. Wolff	11
19	Pharmacological modulation of nitric oxide synthesis by mechanism-based inactivators and related inhibitors 1999 ·Pharmacology & Therapeutics ·Ruslana Bryk,Donald J. Wolff	39
20	Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform 1996 ·British Journal of Pharmacology ·Csaba Szabó,Ruslana Bryk,Basilia Zingarelli,Garry J. Southan,Timothy C. Gahman,Venkat Bhat,Andrew L. Salzman,Donald J. Wolff	45

About Ruslana Bryk

Ruslana Bryk is a scholar working on Biochemistry, Infectious Diseases and Clinical Biochemistry, having authored 25 papers that have together received 2.0k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (15 papers), Tuberculosis Research and Epidemiology (9 papers) and Biochemical Acid Research Studies (7 papers). The work is most often cited by research in Biochemistry (271 citations), Infectious Diseases (638 citations) and Molecular Medicine (141 citations). Ruslana Bryk has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Carl Nathan, Patrick R. Griffin, Hediye Erdjument‐Bromage, Paul Tempst, Christopher D. Lima, Donald J. Wolff, Kyu Y. Rhee, Jing Tian, Aditya Venugopal and Sabine Ehrt. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact